Product NDC: | 55154-0534 |
Proprietary Name: | Glipizide |
Non Proprietary Name: | glipizide |
Active Ingredient(s): | 2.5 mg/1 & nbsp; glipizide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-0534 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020329 |
Marketing Category: | NDA |
Start Marketing Date: | 19940426 |
Package NDC: | 55154-0534-0 |
Package Description: | 10 POUCH in 1 BAG (55154-0534-0) > 1 TABLET, EXTENDED RELEASE in 1 POUCH |
NDC Code | 55154-0534-0 |
Proprietary Name | Glipizide |
Package Description | 10 POUCH in 1 BAG (55154-0534-0) > 1 TABLET, EXTENDED RELEASE in 1 POUCH |
Product NDC | 55154-0534 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | glipizide |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19940426 |
Marketing Category Name | NDA |
Labeler Name | Cardinal Health |
Substance Name | GLIPIZIDE |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |